Publicaciones en colaboración con investigadores/as de Instituto de Química Médica (130)

2024

  1. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis

    Nanoscale, Vol. 16, Núm. 13, pp. 6477-6487

2023

  1. Guiding Clinical Prescription of Topical Extemporaneous Formulations of Sodium Cromoglycate Based on Pharmaceutical Performance

    Pharmaceutics, Vol. 15, Núm. 6

  2. KEAP1-NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

    Medicinal Research Reviews, Vol. 43, Núm. 1, pp. 237-287

  3. Nutrition Security of Hemp for Human Consumption

    Sustainable Food Science - A Comprehensive Approach: Volumes 1-4 (Elsevier), pp. V3-60-V3-88

  4. Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites

    Journal of Medicinal Chemistry, Vol. 66, Núm. 19, pp. 13452-13480

2022

  1. 5-Nitroindazole-based compounds: further studies for activity optimization as anti-Trypanosoma cruzi agents

    Acta Tropica, Vol. 234

  2. Curcumin-piperlongumine hybrids with a multitarget profile elicit neuroprotection in in vitro models of oxidative stress and hyperphosphorylation

    Antioxidants, Vol. 11, Núm. 1

  3. Enantioselective Synthesis and Pharmacological Evaluation of Aza‐CGP37157–Lipoic Acid Hybrids for the Treatment of Alzheimer’s Disease

    Antioxidants, Vol. 11, Núm. 1

  4. Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease

    Antioxidants, Vol. 11, Núm. 2

  5. Novel indolic AMPK modulators induce vasodilatation through activation of the AMPK–eNOS–NO pathway

    Scientific Reports, Vol. 12, Núm. 1

  6. Organotropic dendrons with high potency as HIV-1, HIV-2 and EV-A71 cell entry inhibitors

    European Journal of Medicinal Chemistry, Vol. 237

  7. Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades

    Journal of Medicinal Chemistry, Vol. 65, Núm. 6, pp. 4727-4751

2021

  1. Bisavenathramide analogues as nrf2 inductors and neuroprotectors in in vitro models of oxidative stress and hyperphosphorylation

    Antioxidants, Vol. 10, Núm. 6

  2. Enhanced stability and bioactivity of natural anticancer topoisomerase i inhibitors through cyclodextrin complexation

    Pharmaceutics, Vol. 13, Núm. 10

  3. HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 38, pp. 45279-45290

  4. Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches

    Handbook of Experimental Pharmacology (Springer Science and Business Media Deutschland GmbH), pp. 229-259

  5. Promising hit compounds against resistant trichomoniasis: Synthesis and antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles

    Bioorganic and Medicinal Chemistry Letters, Vol. 37

2020

  1. Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant Trypanosoma cruzi y strain (DTU TcII): In vitro and in vivo studies

    Parasitology, Vol. 147, Núm. 11, pp. 1216-1228

  2. Iron oxide nanoparticles: An alternative for positive contrast in magnetic resonance imaging

    Inorganics, Vol. 8, Núm. 4

  3. Smartphone-Based Colorimetric Method to Quantify Iron Concentration and to Determine the Nanoparticle Size from Suspensions of Magnetic Nanoparticles

    Particle and Particle Systems Characterization, Vol. 37, Núm. 7